Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Expert Review of Pharmacoeconomics & Outcomes Research|December 1, 2017
Bariatric surgery versus conservative management for morbidly obese patients in Spain: a cost-effectiveness analysisRaquel Sanchez-Santos, Esther Mariño Padin, Daniel Adam, et al.
Clinics in Liver Disease|April 6, 2023
Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic Fatty Liver DiseaseJeffrey V Lazarus, Marcela Villota-Rivas, Carolina Jiménez-González, et al.
Plos One|April 1, 2015
Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim studyManuel Romero-Gómez, Juan Turnes, Javier Ampuero, et al.
Gastroenterologia Y Hepatologia|July 1, 2024
Artificial intelligence-assisted identification and retrieval of chronic hepatitis C patients lost to follow-up in the health area of Pontevedra and O Salnés (Spain)Pablo Parada Vázquez, Santiago Pérez-Cachafeiro, Belén Castiñeira Domínguez, et al.
Gastroenterologia Y Hepatologia|January 14, 2015
[Therapeutic decisions in the treatment of hepatocellular carcinoma and patterns of sorafenib use. Results of the international observational GIDEON trial in Spain]Juan Turnes, Roberto Díaz, Manuel Hernandez-Guerra, et al.
Scientific Reports|December 18, 2021
Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry reviewCamila A Picchio, Sabela Lens, Manuel Hernandez-Guerra, et al.
Gastroenterologia Y Hepatologia|June 15, 2021
Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naïve non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE StudyJuan Turnes, Diego Rincón, José L Calleja, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2020
Global real-world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohortsAlessandra Mangia, Scott Milligan, Mandana Khalili, et al.
Gastroenterologia Y Hepatologia|July 6, 2017
The ART-SCORE is not an effective tool for optimizing patient selection for DEB-TACE retreatment. A multicentre Spanish studyMaria Pipa-Muñiz, Lluis Castells, Sonia Pascual, et al.
Gastroenterologia Y Hepatologia|October 18, 2022
Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extractionJavier Crespo, Joaquín Cabezas, Antonio Aguilera, et al.
Pageof 8